Preliminary experiments indicate conolidine might inhibit specific ion channels, reducing neuronal excitability and restricting agony indicators. This mechanism is particularly pertinent in neuropathic soreness, exactly where irregular signaling triggers persistent discomfort. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to ache percepti... https://omarz262lmo2.bmswiki.com/user